Laureen M. Geniusz

FDA investigator

Appears on 10 documents from 2015 to 2026, mostly at sites in Ohio. Most often cites design controls (21 CFR 820.30).

10
Documents on file
4.3
Observations per 483
2015
First seen
2026
Most recent

What they cite most

From 43 observations

Activity by year

2015: 2, 2016: 1, 2017: 3, 2018: 1, 2020: 1, 2023: 1, 2026: 1

Where

Ohio 10

Is Laureen M. Geniusz coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

10 documents, newest first
FirmOpen
483 Compass Health Brands Corp.Feb 27, 2026 · Brookpark, Ohio
483 Frantz Medical Development Ltd.Jun 27, 2023 · Mentor, Ohio
483 Synapse Biomedical IncOct 7, 2020 · Oberlin, Ohio
483 Frantz Medical Development Ltd.Sep 24, 2018 · Mentor, Ohio
483 Philips Medical Systems (Cleveland) IncAug 18, 2017 · Cleveland, Ohio
483 Marlen Manufacturing & Development Co.Mar 13, 2017 · Bedford, Ohio
483 Zuga Medical Inc.Jan 27, 2017 · Beachwood, Ohio

About this profile

What does Laureen M. Geniusz inspect?

Laureen M. Geniusz appears on 10 documents on file covering 9 sites, mostly in Ohio.

What do they cite most often?

21 CFR 820.30 (design controls), followed by 21 CFR 820.100(a) and 21 CFR 820.75.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Laureen M. Geniusz is dated Feb 27, 2026.

FDA Investigator Laureen M. Geniusz: 483s & Inspections · FDA Intel